Financial reports
ARS
2023 FY
Annual report to shareholders
19 Mar 24
10-K
2023 FY
Annual report
28 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
20 Mar 23
10-K
2022 FY
Annual report
27 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
Current reports
8-K
Departure of Directors or Certain Officers
7 Mar 24
8-K
CME Group Inc. Reports Fourth-Quarter and Full-Year 2023 Financial Results
14 Feb 24
8-K
Departure of Directors or Certain Officers
6 Dec 23
8-K
Regulation FD Disclosure
29 Nov 23
8-K
Departure of Directors or Certain Officers
13 Nov 23
8-K
CME Group Inc. Reports Third-Quarter 2023 Financial Results
25 Oct 23
8-K
Regulation FD Disclosure
21 Sep 23
8-K
CME Group Inc. Reports Second-Quarter 2023 Financial Results
26 Jul 23
8-K
Submission of Matters to a Vote of Security Holders
9 May 23
8-K
Entry into a Material Definitive Agreement
28 Apr 23
Registration and prospectus
S-8
Registration of securities for employees
9 Jun 22
424B5
Prospectus supplement for primary offering
3 Mar 22
FWP
Free writing prospectus
1 Mar 22
424B5
Prospectus supplement for primary offering
1 Mar 22
S-3ASR
Automatic shelf registration
1 Mar 22
S-3ASR
Automatic shelf registration
2 Aug 19
424B5
Prospectus supplement for primary offering
15 Jun 18
FWP
Free writing prospectus
14 Jun 18
424B5
Prospectus supplement for primary offering
14 Jun 18
S-3ASR
Automatic shelf registration
4 Dec 15
Proxies
DEFA14A
Additional proxy soliciting materials
21 Mar 24
DEFA14A
Additional proxy soliciting materials
19 Mar 24
DEF 14A
Definitive proxy
18 Mar 24
DEFA14A
Additional proxy soliciting materials
26 Apr 23
DEFA14A
Additional proxy soliciting materials
22 Mar 23
DEFA14A
Additional proxy soliciting materials
16 Mar 23
DEF 14A
Definitive proxy
16 Mar 23
DEF 14A
Definitive proxy
3 Feb 23
DEFA14A
Additional proxy soliciting materials
26 Apr 22
DEFA14A
Additional proxy soliciting materials
23 Mar 22
Other
UPLOAD
Letter from SEC
25 Oct 22
CORRESP
Correspondence with SEC
30 Sep 22
UPLOAD
Letter from SEC
21 Sep 22
UPLOAD
Letter from SEC
23 Dec 19
CORRESP
Correspondence with SEC
19 Dec 19
UPLOAD
Letter from SEC
5 Dec 19
CORRESP
Correspondence with SEC
28 Feb 19
EFFECT
Notice of effectiveness
24 Dec 14
UPLOAD
Letter from SEC
16 Jul 14
CORRESP
Correspondence with SEC
1 Jul 14
Ownership